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A B S T R A C T
Background: Aortic stenosis may be related to coronary atherosclerosis in patients with tricuspid aortic
valve, while aortic dilatation often is present in patients with bicuspid aortic valve. We sought to deﬁne
associations among aortic stenosis, coronary atherosclerosis, and thoracic aortic aneurysm in patients
with tricuspid or bicuspid aortic valve undergoing surgery for aortic stenosis in a large referral medical
center.
Methods: Two hundred seventy patients with severe aortic stenosis (tricuspid 175, bicuspid 95)
undergoing surgical aortic valve replacement (AVR) were studied.
Results: Coronary artery bypass grafting (CABG) surgery plus AVR was required more often in tricuspid
compared to bicuspid aortic valve [62.2% versus 26.3%; p < 0.0001; odds ratio 4.5, conﬁdence interval
(CI) 2.5–8.3]. The incidence of coronary atherosclerosis requiring CABG in bicuspid aortic valve (26.3%)
was greater than that expected in the general population for similar age. Thoracic aorta surgery due to
aortic aneurysm plus AVR was performed more often in bicuspid compared to tricuspid aortic valve
(27.3% versus 3.4%; p < 0.0001; odds ratio 7.7, CI 3.0–22.1). The incidence of ascending aorta aneurysm
requiring surgery, however, was not more common in tricuspid aortic valve (3.4%) to that expected in the
general population for similar age.
Conclusion: Incidence of coronary atherosclerosis is high in patients with aortic stenosis, both in those
with tricuspid and bicuspid aortic valve. Incidence of ascending aortic aneurysm is high in patients with
bicuspid, but not those with tricuspid aortic valve. These ﬁndings should be taken into consideration in
the evaluation and management of patients with the aortic stenosis complex.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Traditionally, it was thought that calciﬁc aortic stenosis in
patients with a tricuspid aortic valve was related to valve
degeneration due to aging caused by several years of mechanical
stress and biologic response to such injury. Recent developments,
however, suggest that calciﬁc aortic stenosis in patients with a
tricuspid aortic valve may be related to coronary atherosclerosis,
and that the initiating pathogenetic mechanisms are similar in
both disorders [1–3].
Bicuspid aortic valve is familial and present in approximately
2% of live births [4,5]. Patients with a bicuspid aortic valve typically* Corresponding author at: The Ohio State University, Department of Medicine/
Cardiovascular Medicine, 473 W. 12th Avenue, Suite 200, Columbus, OH 43210, USA.
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0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsdevelop aortic stenosis at a younger age, usually before the age of
65 years, compared to aortic stenosis in patients with a tricuspid
aortic valve, which more often develops after the age of 70 years
[6,7]. Aortic stenosis in patients with a bicuspid aortic valve, which
often is associated with aortic dilatation with the potential for
dissection, may also be related to atherosclerosis [5,8–10].
Although associations between aortic stenosis in patients with a
tricuspid aortic valve and coronary atherosclerosis, and aortic
dilatation in patients with a bicuspid aortic have been suggested,
the incidence of atherosclerosis in patients with a bicuspid aortic
valve and aortic dilatation in those with a tricuspid aortic valve have
not been well deﬁned. Furthermore, these interrelationshipsin
patients requiring aortic valve surgery for aortic stenosis are not well
known. The present study was undertaken to investigate associa-
tions between aortic stenosis and coronary atherosclerosis, and
between aortic stenosis and thoracic aortic aneurysm, in patients
with tricuspid and bicuspid aortic valve who had surgical aortic
valve replacement in a large tertiary-care referral medical center. reserved.
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Study population
Medical records from The Ohio State University Wexner
Medical Center (Columbus, OH, USA), a large referral center, were
reviewed from January 2002 to June 2008. The study was approved
by The Ohio State University Institutional Review Board. A total
of 270 patients who had open-heart surgery for single aortic valve
replacement due to severe aortic stenosis were identiﬁed. In these
patients, aortic valve area was less than 1.0 cm2 or less than
0.6 cm2/m2; 175 patients had tricuspid and 95 had bicuspid aortic
valve (Fig. 1). One hundred and nine patients with a tricuspid aortic
valve and aortic stenosis (62.2%), and 25 (26.3%) patients with a
bicuspid aortic valve and aortic stenosis, had concomitant
coronary artery bypass grafting (CABG) surgery for signiﬁcant
coronary artery disease; signiﬁcant coronary artery disease was
deﬁned as a 70% stenosis or greater in at least one major coronary
artery as determined by selective coronary arteriography.
Six patients (3.4%) with a tricuspid aortic valve and aortic
stenosis, and 26 patients (27.3%) with a bicuspid aortic valve and
aortic stenosis, had concomitant surgery for thoracic aortic
aneurysm. Aortic dilatation requiring surgery was considered
when the diameter of the ascending aorta was equal to or greater
than 5.0 cm as determined by aortography and/or echocardiogra-
phy. The number of aortic valve leaﬂets, tricuspid or bicuspid, was
conﬁrmed in all patients preoperatively by echocardiogram and by
the surgeon in the operating room; the presence of tricuspid or
bicuspid aortic valve was also conﬁrmed by pathologic examina-
tion. In-hospital surgical mortality and length-of-stay were also
determined. Hospital length-of-stay included only patients who
survived hospitalization. Due to the wide range in hospital length-
of-stay with potential outliers, both median and mean values are
presented.
Statistical analysis
Descriptive data are expressed as either mean  standard
deviation or as a median with a low and high range. The association
of signiﬁcant coronary artery disease or signiﬁcant dilatation of the
thoracic aorta in relation to tricuspid or bicuspid aortic valve was
determined using logistic regression analysis adjusting for age and
gender. The Student’s t-test was used to detect differences between
means of age and log transformed hospital length-of-stay for patients
with tricuspid or bicuspid aortic valve. To deﬁne if there was a
statistically signiﬁcant difference in gender, traditional risk factors,Fig. 1. Aortic stenosis in patients with tricuspid or bicuspid aortic valve who had surgi
grafting (CABG) surgery and/or thoracic aorta surgery; () indicates no surgery, (+) indand in-hospital surgical mortality between groups a Fisher’s exact
test or a Chi-square test was performed where appropriate. Wilcoxon
rank-sum test was used to determine difference in median length-of-
stay between groups. A p-value <0.05 was considered statistically
signiﬁcant.
Results
Patients with a bicuspid aortic valve were on average 9 years
younger than patients with a tricuspid aortic valve at the time of
aortic valve replacement, 62  13 years and 71  10 years, respec-
tively (p < 0.0001); however, there was some overlap in which
several patients with a bicuspid aortic valve and aortic stenosis were
older than 70 years, and several patients with a tricuspid aortic valve
and aortic stenosis were younger than 60 years. There was a
predominance of males in the entire cohort; however, this was more
pronounced among those with a bicuspid (71.6%) compared to those
with a tricuspid (55.4%) aortic valve (p < 0.05). In tricuspid and
bicuspid aortic valve, history of arterial hypertension (87% versus
70%, respectively; p = 0.001) and diabetes mellitus (47% versus 31%,
respectively; p = 0.016) were greater in patients with a tricuspid
aortic valve, while history of hyperlipidemia (60% versus 61%,
respectively) and smoking (48% versus 53%, respectively) were not
statistically different between the two groups.
Individual patients with aortic stenosis (tricuspid or bicuspid
aortic valve) requiring aortic valve replacement with or without
concomitant CABG surgery are shown in Fig. 2. In order to better
compare the frequency of coronary artery disease in different ages
between tricuspid and bicuspid aortic valve, patients were divided
into six subgroups as shown in Fig. 3. Although the frequency of
coronary artery disease increases with age, incidence of coronary
artery disease at any age was higher in patients with tricuspid
compared with bicuspid aortic valve.
The overall incidence of signiﬁcant coronary artery disease
requiring CABG at the time of aortic valve replacement was
signiﬁcantly greater in patients with a tricuspid compared to
those with a bicuspid aortic valve, 109 out of 175 (62.2%) versus
25 out of 95 (26.3%), respectively (p < 0.0001; Fig. 4A); odds ratio
4.5 with a conﬁdence interval (CI) 2.5–8.3 (p < 0.0001; Fig. 4B)
adjusted for age (p = 0.0088) and gender (p = 0.0005). The
incidence of coronary artery disease requiring CABG, however,
in patients with a bicuspid aortic valve and aortic stenosis appears
to be greater to that expected in a population of the United States
of America (USA) with similar age [11].
The incidence of signiﬁcant ascending aortic aneurysm requir-
ing thoracic aortic surgery in relation to age is shown in Fig. 5. It cancal aortic valve replacement with or without concomitant coronary artery bypass
icates surgery.
Fig. 2. Individual patients with aortic stenosis (tricuspid or bicuspid aortic valve)
requiring aortic valve replacement with or without concomitant coronary artery
bypass grafting (CABG) surgery are shown.
Fig. 4. (A) Aortic stenosis in patients with tricuspid or bicuspid aortic valve who had
aortic valve replacement with concomitant coronary artery bypass grafting (CABG)
surgery. (B) The incidence of signiﬁcant coronary artery disease requiring CABG
surgery was greater in patients with a tricuspid compared to those with a bicuspid
aortic valve; odds ratio 4.5, 95% conﬁdence interval 2.5–8.3.
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surgery decreases with age in patients with a bicuspid aortic valve.
Due to the small number of patients with a tricuspid aortic valve
and thoracic aortic aneurysm (6 out of 175), they were not
included in the ﬁgure.
The overall incidence of thoracic aortic aneurysm was
signiﬁcantly greater in patients with a bicuspid compared to
those with a tricuspid aortic valve, 26 out of 95 (27.3%) versus 6 out
of 175 (3.4%), respectively (p < 0.0001; Fig. 6A); odds ratio 7.7 with
a CI 3.0–22.1 (p < 0.0001; Fig. 6B) adjusted for age (p = 0.016).
Gender was not a signiﬁcant predictor of aortic aneurysm. The
incidence of thoracic aortic aneurysm requiring surgery, however,
in patients with a tricuspid aortic valve and aortic stenosis was low
and did not appear to be greater to that expected in a population of
the USA with similar age [12,13].
The overall in-hospital surgical mortality for aortic valve
replacement in patients with a tricuspid aortic valve was 16 out
of 175 (9.1%), while in those with a bicuspid aortic valve was 4 out
of 95 (4.2%; p = 0.22). In-hospital surgical mortality in patients
with a tricuspid aortic valve undergoing only valve surgery wasFig. 3. Frequency of concomitant coronary artery bypass grafting (CABG) surgery in
patients undergoing aortic valve replacement for aortic stenosis (tricuspid or
bicuspid aortic valve). The incidence of CABG surgery at any age was higher in
patients with tricuspid compared to those with bicuspid aortic valve. The incidence
of CABG increased with age in both groups.2 out of 62 (3.2%), aortic valve surgery with concomitant CABG was
14 out of 107 (13.0%), and aortic valve surgery with concomitant
thoracic aortic aneurysm surgery was 0 out of 4 (0%). In-hospital
surgical mortality in patients with a bicuspid aortic valve
undergoing only valve surgery was 3 out of 51 (5.8%), aortic valve
surgery with concomitant CABG was 1 out of 18 (5.5%), and aortic
valve surgery with concomitant thoracic aortic aneurysm surgery
was 0 out of 19 (0%). The number of patients, however, in these
subgroups was too small to allow further statistical analysis.Fig. 5. Frequency of concomitant thoracic aortic aneurysm surgery in patients with
a bicuspid aortic valve undergoing aortic valve replacement for aortic stenosis. The
incidence of thoracic aortic aneurysm requiring surgery was higher in younger age
(p = 0.016).
Fig. 6. (A) Aortic stenosis in patients with tricuspid or bicuspid aortic valve who had
surgical aortic valve replacement with concomitant surgery of the thoracic aorta.
(B) The incidence of signiﬁcant dilatation of the thoracic aorta requiring surgery was
greater in patients with a bicuspid compared to those with a tricuspid aortic valve;
odds ratio 7.7, 95% conﬁdence interval 3.0–22.1.
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with a bicuspid compared to those with a tricuspid aortic valve,
9.7  6.7 and 12.4  10.7 days, respectively (p < 0.05). Median
length-of-stay was also shorter in patients with a bicuspid (8 days;
range 3–42 days) compared to patients with a tricuspid aortic valve
(9 days; range 4–89 days), however, this did not reach statistical
signiﬁcance (p = 0.06).
Discussion
This study demonstrates that there is an interrelationship
between aortic stenosis, coronary atherosclerosis, and thoracicFig. 7. Interrelationships between bicuspid aortic valve, tricuspid aortic valve, aortic ane
of the valve is the primary disorder for the development of aortic stenosis (thick arrow); r
development of aortic stenosis in tricuspid aortic valve (thick arrow), but mild anatomic a
aortic valve, while coronary atherosclerosis is present in aortic stenosis of both bicuspaortic aneurysm. The incidence of coronary artery disease
requiring CABG was exceptionally high in patients with a tricuspid
aortic valve (62%), which was higher than those with a bicuspid
aortic valve (26%). The incidence of coronary artery disease
requiring CABG, however, in patients with a bicuspid aortic valve
was much greater than that expected in the general population
with similar age as reported by USA national statistics [11]. This
suggests that risk factors related to the development of athero-
sclerosis may also contribute to the development of aortic stenosis
even in patients with a bicuspid aortic valve. The lower incidence
of atherosclerosis at any given age, however, in patients with a
bicuspid compared to those with a tricuspid aortic valve suggests
that the contribution of atherosclerotic risk factors in the
development of aortic stenosis is greater in patients with a
tricuspid compared to those with a bicuspid aortic valve. Anatomic
abnormality of the valve is the dominating factor in patients with
aortic stenosis and bicuspid aortic valve [4,5]. As expected, the
incidence of thoracic aortic aneurysm was higher (27%) in patients
with a bicuspid compared to those with a tricuspid aortic valve
(3.4%). The incidence of thoracic aortic aneurysm requiring
surgery, however, in patients with a tricuspid aortic valve does
not appear to be higher than that expected in the general
population with similar age in the USA according to national
statistics [12,13]. Due to the strong association between valvular
aortic stenosis, coronary atherosclerosis, and aneurysm of the
ascending aorta, aortic stenosis should be considered as a cluster of
diseases or abnormalities that constitute ‘‘the aortic stenosis
complex’’ (Fig. 7).
Traditionally, calciﬁcation of a tricuspid aortic valve resulting in
aortic sclerosis and/or stenosis was believed to be related to
degeneration of the valve secondary to aging caused by mechanical
trauma over the years that typically becomes signiﬁcant in the
seventh decade of life or later [1,2,6]. More recently, however,
evidence has suggested that risk factors responsible for the
pathogenesis of atherosclerosis are also related to the develop-
ment of aortic calciﬁcation and stenosis [3,14–17]. It is speculated
that the initial event in the development of aortic stenosis is
endothelial damage due to high mechanical stress and low shear
stress; this allows lipids to penetrate the damaged endothelium
[2,18–21]. As oxidation of low-density lipoproteins occurs, an
inﬂammatory process is initiated with the accumulation of T-cells,
monocytes, mast cells, and CD3 positive leukocytes [1–3,21–23].
Inﬂammation also activates angiogenesis that may result inurysm, and coronary atherosclerosis. In bicuspid aortic valve, anatomic abnormality
isk factors may also contribute. In contrast, risk factors are the primary cause for the
bnormalities of the valve may also play a role. Aortic aneurysm is present in bicuspid
id and tricuspid aortic valves, however, more common in tricuspid aortic valve.
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contributing to the progression of stenosis [2,24]. In this
inﬂammatory process, ﬁbroblast like-cells called ‘‘valve interstitial
cells’’ accumulate promoting the formation of ﬁbrous tissue in
which some of the valve interstitial cells transform into
myoﬁbroblasts differentiating into osteoblasts promoting calciﬁ-
cation. The higher pressure found on the left side of the heart most
likely also plays a role in calcium formation, as calciﬁcation of the
valves of the right side of the heart is rarely seen [2,25–27].
Even though there are apparent similarities in the underlying
processes, it is not clear why many patients with coronary artery
disease do not develop aortic stenosis. It has been suggested that
even in normal appearing trileaﬂet aortic valves, the size of the
three leaﬂets may vary slightly and this anatomic variation in
certain individuals may predispose to the formation of aortic
stenosis [28]. There may also be a genetic predisposition to aortic
calciﬁcation as different lipoprotein(a) expression levels encoded
by the lipoprotein(a) gene have been associated with varying
degrees of aortic valve calciﬁcation and stenosis [29,30].
It has been well documented that a bicuspid aortic valve, in
addition to aortic stenosis, is also associated with aortopathy
[4,5,8]. Aortic dilatation in patients with a bicuspid aortic valve is
due to abnormalities in the medial architecture of the aortic wall
where there is a loss of smooth muscle cells and fragmentation
of elastin ﬁbers resulting in progressive aortic dilatation [31,32].
This study demonstrated that approximately 27% of patients with
aortic stenosis and a bicuspid aortic valve required concomitant
surgery for thoracic aortic aneurysm as compared to only
approximately 3% of patients with aortic stenosis and a tricuspid
aortic valve. Thus, thoracic aortic aneurysm is mostly seen in
patients with a bicuspid aortic valve, while it is unusual in patients
with aortic stenosis and a tricuspid aortic valve. Traditionally, it
was thought that aortic stenosis was responsible for the aortic
dilatation, the so-called ‘‘post-stenotic aortic dilatation’’; it is
plausible, however, that this false impression was based mostly on
patients with a bicuspid aortic valve [33]. In addition, it should be
emphasized that all patients with coronary artery disease have
functional abnormalities of the aorta (i.e. aortopathy). Thus,
aortopathy (stiff aorta) is present in almost all patients with
coronary artery disease and aortic stenosis, regardless of the
etiology, even with a normal size aorta as deﬁned by imaging
techniques [8].
In cases where aortic stenosis and coronary artery disease co-
exist, and if both diseases are severe, surgery is usually performed
simultaneously. If aortic stenosis is not severe and the patient
needs surgery for coronary artery disease, indications for aortic
valve replacement at the same time are less well deﬁned. In this
case, the severity and the progression of aortic stenosis (assuming
that serial echocardiograms are available), and several other
factors such as age, co-morbidities, and life expectancy, should be
taken into consideration. In this study, however, all patients had
severe aortic stenosis, which was the primary indication for
surgery. Requiring CABG at the time of aortic valve replacement
was used to deﬁne if a patient had concomitant coronary artery
disease and thus, may have not accounted for patients with non-
obstructive coronary artery disease. Also, requiring thoracic aortic
aneurysm surgery at the time of aortic valve replacement was used
to deﬁne if a patient had signiﬁcant dilatation of the thoracic aorta
and thus, may have not accounted for individuals with mild
dilatation of the aorta that did not require surgery. However, using
CABG and/or aorta surgery as deﬁnitions for coronary artery
disease and thoracic aortic aneurysm, respectively, suggests that
these associations may be even stronger since less severe disease
may have not been included in the analysis.
There are several clinical implications related to this study.
The close association between aortic stenosis and coronaryatherosclerosis and/or thoracic aortic aneurysm suggests that
patients with aortic stenosis should be evaluated for coronary
artery disease and aortic aneurysm. When aortic aneurysm is
present in patients with aortic stenosis, bicuspid aortic valve
most likely is the underlying etiology of the disease. It follows that
ﬁrst-degree relatives of these patients should be evaluated to
exclude or conﬁrm a bicuspid aortic valve. Patients who develop
aortic stenosis, particularly those with a tricuspid aortic valve, as
a general rule, have a systolic aortic murmur for decades prior to
the development of severe disease; this gives an opportunity for
prevention (coronary artery disease and possibly aortic stenosis)
with risk factor modiﬁcation of coronary artery disease. The same
is true for patients with a bicuspid aortic valve since risk factors
contributing to the development of atherosclerosis may also
contribute to the development of aortic stenosis in these patients
[34]. Concomitant aortic valve replacement and CABG surgery
may substantially increase mortality [35]. Thus, a hybrid approach
(i.e. aortic valve replacement plus percutaneous coronary inter-
vention) in certain high-risk patients may be preferable given the
fact that these diseases are chronic and such an approach with
appropriate planning can be accomplished. Traditionally, it is
believed that aortic stenosis in bicuspid aortic valve occurs before
the age of 70 years, while tricuspid aortic valve occurs after the age
of 70 years. In general this is true, but several patients with
bicuspid aortic valve may develop severe aortic stenosis after the
age of 70 years, while patients with tricuspid aortic valve may
develop severe aortic stenosis before the age of 70 years.
In conclusion, the incidence of coronary artery disease is
extremely high in patients with aortic stenosis and tricuspid aortic
valve. The data also suggest that there is an association between
coronary atherosclerosis and aortic stenosis in patients with a
bicuspid aortic valve. The incidence of thoracic aortic aneurysm is
high in patients with a bicuspid aortic valve and aortic stenosis.
The incidence of thoracic aortic aneurysm, however, in patients
with a tricuspid aortic valve and aortic stenosis was low and at
least not greater than that expected in the general population.
These ﬁndings should be taken into consideration in the evaluation
and management of patients with the aortic stenosis complex.
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